Glenmede Trust’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,707
Closed -$303K 1332
2022
Q2
$303K Buy
6,707
+1,657
+33% +$74.9K ﹤0.01% 1001
2022
Q1
$384K Buy
5,050
+48
+1% +$3.65K ﹤0.01% 973
2021
Q4
$745K Sell
5,002
-3
-0.1% -$447 ﹤0.01% 820
2021
Q3
$728K Sell
5,005
-148
-3% -$21.5K ﹤0.01% 790
2021
Q2
$1.01M Buy
+5,153
New +$1.01M 0.01% 703